Epstein-Barr virus-induced miR-155 attenuates NF-κB signaling and stabilizes latent virus persistence

Journal of Virology

Volumn 82, Issue 21, 2008, Pages 10436-10443

  Lu, Fang ^a   Weidmer, Andreas ^a   Liu, Chang Gong ^b   Volinia, Stefano ^b   Croce, Carlo M ^b   Lieberman, Paul M ^a  

^a WISTAR INSTITUTE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B KINASE EPSILON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LATENCY MEMBRANE PROTEIN 1; PROTEIN MIR 155; RNA; UNCLASSIFIED DRUG; VIRUS PROTEIN; MICRORNA; MIRN155 MICRORNA, HUMAN;

ARTICLE; B LYMPHOCYTE; CELL IMMORTALIZATION; CONTROLLED STUDY; EPSTEIN BARR VIRUS; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; INNATE IMMUNITY; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; SIGNAL TRANSDUCTION; CELL CULTURE; CELL LINE; DRUG ANTAGONISM; METABOLISM; PHYSIOLOGY; VIROLOGY; VIRUS LATENCY;

HUMAN HERPESVIRUS 4;

B-LYMPHOCYTES; CELL LINE; CELLS, CULTURED; HERPESVIRUS 4, HUMAN; HUMANS; MICRORNAS; NF-KAPPA B; VIRUS LATENCY;

EID: 55249124589     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00752-08     Document Type: Article

References (39)

1. Agami, R. 2007. All roads lead to IKKε. Cell 129:1043-1045.
2. Calame, K. 2007. microRNA-155 function in B cells. Immunity 27:825-827.
3. Costinean, S., N. Zanesi, Y. Pekarsky, E. Tili, S. Volinia, N. Heerema, and C. M. Croce. 2006. Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice. Proc. Natl. Acad. Sci. USA 103:7024-7029.
4. Cullen, B. R. 2006. Viruses and microRNAs. Nat. Genet. 38(Suppl.):S25-S30.
5. Dirmeier, U., R. Hoffmann, E. Kilger, U. Schultheiss, C. Briseno, O. Gires, A. Kieser, D. Eick, B. Sugden, and W. Hammerschmidt. 2005. Latent membrane protein 1 of Epstein-Barr virus coordinately regulates proliferation with control of apoptosis. Oncogene 24:1711-1717.
6. Engels, B. M., and G. Hutvagner. 2006. Principles and effects of microRNA-mediated posttranscriptional gene regulation. Oncogene 25:6163-6169.
7. Esquela-Kerscher, A., and F. J. Slack. 2006. Oncomirs: microRNAs with a role in cancer. Nat. Rev. Cancer 6:259-269.
8. Gottwein, E., N. Mukherjee, C. Sachse, C. Frenzel, W. H. Majoros, J. T. Chi, R. Braich, M. Manoharan, J. Soutschek, U. Ohler, and B. R. Cullen. 2007. A viral microRNA functions as an orthologue of cellular miR-155. Nature 450:1096-1099.
9. Grey, F., L. Hook, and J. Nelson. 2007. The functions of herpesvirus-encoded microRNAs. Med. Microbiol. Immunol. 197:261-267.
10. Hacker, H., and M. Karin. 2006. Regulation and function of IKK and IKK-related kinases. Sci. STKE 2006:re13.
11. Hannon, G. J., F. V. Rivas, E. P. Murchison, and J. A. Steitz. 2006. The expanding universe of noncoding RNAs. Cold Spring Harbor Symp. Quant. Biol. 71:551-564.
12. Hiscott, J. 2007. Convergence of the NF-κB and IRF pathways in the regulation of the innate antiviral response. Cytokine Growth Factor Rev. 18:483-490.
13. Izumi, K. M. 2004. Epstein-Barr virus signal transduction and B-lymphocyte growth transformation. Prog. Mol. Subcell. Biol. 36:269-288.
14. Kieff, E. 2007. Epstein-Barr virus and its replication, 5th ed. Wolters Kluwer Health/Lippincott/The Williams & Wilkins Co., Philadelphia, PA.
15. Kluiver, J., E. Haralambieva, D. de Jong, T. Blokzijl, S. Jacobs, B. J. Kroesen, S. Poppema, and A. van den Berg. 2006. Lack of BIC and microRNA miR-155 expression in primary cases of Burkitt lymphoma. Genes Chromosomes Cancer 45:147-153.
16. Kluiver, J., S. Poppema, D. de Jong, T. Blokzijl, G. Harms, S. Jacobs, B. J. Kroesen, and A. van den Berg. 2005. BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B-cell lymphomas. J. Pathol. 207:243-249.
17. Kluiver, J., A. van den Berg, D. de Jong, T. Blokzijl, G. Harms, E. Bouwman, S. Jacobs, S. Poppema, and B. J. Kroesen. 2007. Regulation of primicroRNA BIC transcription and processing in Burkitt lymphoma. Oncogene 26:3769-3776.
18. Krutzfeldt, J., N. Rajewsky, R. Braich, K. G. Rajeev, T. Tuschl, M. Manoharan, and M. Stoffel. 2005. Silencing of microRNAs in vivo with "antagomirs." Nature 438:685-689.
19. Liu, C. G., G. A. Calin, B. Meloon, N. Gamliel, C. Sevignani, M. Ferracin, C. D. Dumitru, M. Shimizu, S. Zupo, M. Dono, H. Alder, F. Bullrich, M. Negrini, and C. M. Croce. 2004. An oligonucleotide microchip for genomewide microRNA profiling in human and mouse tissues. Proc. Natl. Acad. Sci. USA 101:9740-9744.
20. Motsch, N., T. Pfuhl, J. Mrazek, S. Barth, and F. A. Grasser. 2007. Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) induces the expression of the cellular microRNA miR-146a. RNA Biol. 4:131-137.
21. O'Connell, R. M., K. D. Taganov, M. P. Boldin, G. Cheng, and D. Baltimore. 2007. MicroRNA-155 is induced during the macrophage inflammatory response. Proc. Natl. Acad. Sci. USA 104:1604-1609.
22. Perkins, N. D. 2007. Integrating cell-signalling pathways with NF-κB and IKK function. Nat. Rev. Mol. Cell. Biol. 8:49-62.
23. Pfeffer, S., and O. Voinnet. 2006. Viruses, microRNAs and cancer. Oncogene 25:6211-6219.
24. Rickinson, A. B., and E. Kieff. 2007. Epstein-Barr virus, 5th ed. Wolters Kluwer Health/Lippincott/The Williams & Wilkins Co., Philadelphia, PA.
25. Rodriguez, A., E. Vigorito, S. Clare, M. V. Warren, P. Couttet, D. R. Soond, S. van Dongen, R. J. Grocock, P. P. Das, E. A. Miska, D. Vetrie, K. Okkenhaug, A. J. Enright, G. Dougan, M. Turner, and A. Bradley. 2007. Requirement of bic/microRNA-155 for normal immune function. Science 316:608-611.
26. Schlee, M., M. Holzel, S. Bernard, R. Mailhammer, M. Schuhmacher, J. Reschke, D. Eick, D. Marinkovic, T. Wirth, A. Rosenwald, L. M. Staudt, M. Eilers, F. Baran-Marszak, R. Fagard, J. Feuillard, G. Laux, and G. W. Bornkamm. 2007. c-myc activation impairs the NF-κB and the interferon response: implications for the pathogenesis of Burkitt's lymphoma. Int. J. Cancer 120:1387-1395.
27. Sharma, S., B. R. tenOever, N. Grandvaux, G. P. Zhou, R. Lin, and J. Hiscott. 2003. Triggering the interferon antiviral response through an IKK-related pathway. Science 300:1148-1151.
28. Skalsky, R. L., M. A. Samols, K. B. Plaisance, I. W. Boss, A. Riva, M. C. Lopez, H. V. Baker, and R. Renne. 2007. Kaposi's sarcoma-associated herpesvirus encodes an ortholog of miR-155. J. Virol. 81:12836-12845.
29. Soni, V., E. Cahir-McFarland, and E. Kieff. 2007. LMP1 TRAFficking activates growth and survival pathways. Adv. Exp. Med. Biol. 597:173-187.
30. Tam, W., D. Ben-Yehuda, and W. S. Hayward. 1997. bic, a novel gene activated by proviral insertions in avian leukosis virus-induced lymphomas, is likely to function through its noncoding RNA. Mol. Cell. Biol. 17:1490-1502.
31. Thai, T. H., D. P. Calado, S. Casola, K. M. Ansel, C. Xiao, Y. Xue, A. Murphy, D. Frendewey, D. Valenzuela, J. L. Kutok, M. Schmidt-Supprian, N. Rajewsky, G. Yancopoulos, A. Rao, and K. Rajewsky. 2007. Regulation of the germinal center response by microRNA-155. Science 316:604-608.
32. Thorley-Lawson, D. A. 2001. Epstein-Barr virus: exploiting the immune system. Nat. Rev. Immunol. 1:75-82.
33. Tili, E., J. J. Michaille, A. Cimino, S. Costinean, C. D. Dumitru, B. Adair, M. Fabbri, H. Alder, C. G. Liu, G. A. Calin, and C. M. Croce. 2007. Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. J. Immunol. 179:5082-5089.
34. Vigorito, E., K. L. Perks, C. Abreu-Goodger, S. Bunting, Z. Xiang, S. Kohlhaas, P. P. Das, E. A. Miska, A. Rodriguez, A. Bradley, K. G. Smith, C. Rada, A. J. Enright, K. M. Toellner, I. C. Maclennan, and M. Turner. 2007. microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells. Immunity 27:847-859.
35. Werner, S. L., D. Barken, and A. Hoffmann. 2005. Stimulus specificity of gene expression programs determined by temporal control of IKK activity. Science 309:1857-1861.
36. Yin, Q., J. McBride, C. Fewell, M. Lacey, X. Wang, Z. Lin, J. Cameron, and E. K. Flemington. 2008. microRNA-155 is an Epstein-Barr virus induced gene that modulates Epstein Barr virus regulated gene expression pathways. J. Virol.
37. Yin, Q., X. Wang, J. McBride, C. Fewell, and E. Flemington. 2008. B-cell receptor activation induces BIC/miR-155 expression through a conserved AP-1 element. J. Biol. Chem. 283:2654-2662.
38. Young, L. S., and A. B. Rickinson. 2004. Epstein-Barr virus: 40 years on. Nat. Rev. Cancer 4:757-768.
39. Zhao, Y., and D. Srivastava. 2007. A developmental view of microRNA function. Trends Biochem. Sci. 32:189-197.